Search for an NAD vitamin and the shelf can make it look as if NAD belongs beside Vitamin C or Vitamin D. The chemistry is different here. NAD is a coenzyme your cells use constantly, while Vitamin B3 is part of the nutrient family your body can use to make NAD and includes compounds that can feed NAD synthesis. That difference is why some supplements contain a precursor such as nicotinamide riboside rather than NAD itself.
Goli’s 2018 launch now sits more than ten billion gummy units behind a brand presence that spans markets worldwide. That scale says a lot about the popularity of the format, but it does not change the chemistry. For NAD products, the useful question is still what molecule is actually in the gummy and what your body can turn it into.
The Short Answer
An NAD vitamin is not a separate vitamin category. NAD is a coenzyme your body makes from Vitamin B3-related precursors, including nicotinamide, nicotinic acid, and nicotinamide riboside, and human trials show that NR can raise NAD-related biomarkers. The practical takeaway for this decision is simple: identify the actual B3-related form on the label before judging what the supplement can do.
Why NAD and Vitamin B3 Get Blurred Together
The confusion is understandable because the two are directly connected.
Vitamin B3 is the nutrient family.
NAD is one of the major coenzymes that family helps your body build.
The NIH Office of Dietary Supplements describes niacin as Vitamin B3 and notes that tissues convert absorbed niacin into NAD, a coenzyme required by hundreds of enzymes. It also lists nicotinamide riboside as a related niacin derivative. The NIH niacin fact sheet is the cleanest way to separate the terms because it puts the nutrient and the coenzyme in the same pathway without calling them the same thing.
That distinction matters commercially.
A bottle can use NAD in the product name while the ingredient panel contains a precursor. In many cases, that is exactly what you want to see because the human supplementation evidence is largely about precursors rather than about swallowing intact NAD and assuming it reaches cells unchanged.
Two Different Jobs: Vitamin In, Coenzyme Out
Think of Vitamin B3 and NAD as two different jobs in the same system.
Vitamin B3 is input. Nicotinic acid, nicotinamide, and related compounds such as NR can feed pathways the body uses to maintain NAD.
NAD is working machinery. It cycles between oxidized and reduced forms in reactions involved in energy metabolism and also serves as a substrate for enzymes involved in cell signaling and repair.
The difference is practical.
If you are shopping for a supplement, you are not really choosing whether NAD is “better” than Vitamin B3. You are choosing which input the product gives your body and whether that input has human data behind it.
NR is one of those inputs.
In an eight-week randomized dose-ranging trial, 100, 300, and 1,000 mg of NR chloride produced dose-dependent increases in whole-blood NAD+ and related metabolites. The Scientific Reports trial was funded by ChromaDex, two authors were employees, and another author had intellectual-property and advisory ties to the company, so that commercial relationship belongs beside the result.
The useful point is narrow.
NR can raise the biomarker.
That does not mean every outcome people associate with NAD will improve.
How to Read an NAD Supplement Without Mixing Up the Molecules
Step One: Check Whether the Label Says NAD or a Precursor
Start with the Supplement Facts panel.
If it lists nicotinamide riboside, nicotinamide, nicotinic acid, or NMN, you are looking at a precursor strategy.
If it lists NAD itself, that is a different proposition.
The distinction matters because current human research is much deeper for oral precursors than for direct oral NAD. A 2026 review of NAD-related approaches notes that direct delivery of intact NAD to tissues and cells remains uncertain, while the human oral evidence is much deeper for precursor supplementation that feeds NAD synthesis. The Frontiers review also emphasizes how limited the clinical-outcome evidence remains for direct NAD approaches.
Step Two: Identify Which B3-Related Form You Are Getting
“Vitamin B3” is not one molecule.
Nicotinic acid and nicotinamide are classic B3 forms. NR is a related B3 form that enters NAD metabolism through a different route.
That difference can matter for tolerability, dose, and research history.
Nicotinic acid, for example, is the form associated with the familiar niacin flush at supplemental doses. NR is not usually discussed as a flushing ingredient in human trials.
The word B3 tells you the family.
The specific form tells you the product.
Step Three: Compare the Exact Molecule With Human Trials
Do not compare a generic “NAD blend” with an NR trial.
Do not compare an NMN study with an NR product as if the two were interchangeable.
And do not assume that because several molecules can eventually feed NAD metabolism, they have identical evidence.
A small placebo-controlled crossover trial in older men found that 1,000 mg per day of NR for 21 days altered the skeletal-muscle NAD metabolome but did not improve mitochondrial bioenergetics. The Cell Reports study also involved ChromaDex-linked NR supply and investigator relationships, which is worth knowing when interpreting a branded precursor literature.
That is a useful example of the difference between target engagement and a felt benefit.
The chemistry moved.
The functional endpoint did not automatically follow.
Step Four: Keep Biomarker Effects Separate From Health Claims
This is the step most product pages skip.
A supplement can raise NAD-related metabolites without proving that it improves energy, weight, cognition, recovery, or longevity in healthy adults.
A 12-week randomized trial in men with obesity and insulin resistance tested 2,000 mg per day of NR and found no improvement in glucose tolerance, pancreatic hormone responses, or incretin hormones. The JCEM trial is useful precisely because the negative result keeps the category honest.
More recently, a 2026 systematic review found that oral NR and NMN consistently showed biochemical target engagement in human studies, while functional, metabolic, vascular, and other healthspan outcomes were mixed or often null. The Aging Research Reviews paper is the broadest current summary of that gap.
Biomarkers are real.
Benefits still have to be demonstrated one endpoint at a time.
The Vitamin Myth Hiding Inside the Name
The easiest mistake is to think that if NAD comes from Vitamin B3, taking more B3 must simply create more NAD and therefore more energy.
That collapses several steps into one.
Your body regulates NAD synthesis, recycling, and consumption. Different B3 forms enter different parts of that network, and doses that exceed nutritional requirements do not turn metabolism into a straight line where twice the input creates twice the useful outcome.
The second version of the same myth is that NAD must be a vitamin because supplements sell it beside vitamins. Shelf placement is not biochemistry. NAD is a coenzyme.
Then there is the word “natural,” which does not solve anything here. NAD occurs naturally in cells, B3 occurs naturally in food, and NR occurs in trace amounts in foods, but none of those facts tells you whether a supplemental dose has been tested in people.
And the final leap is assuming a vitamin-derived molecule must be harmless at any dose.
That is not how supplements work.
The form and amount still matter.
What a Realistic NAD Result Looks Like
The strongest and most repeatable human finding is biochemical: precursor supplementation can raise blood NAD+ or related metabolites.
That is measurable.
It is not the same thing as feeling stimulated.
A 2026 phase I pharmacokinetic study gave oral NR or NMN to 12 participants, including healthy adults and people with Parkinson’s disease, and found that blood NAD rose gradually and approached a plateau after about two weeks. Brain NAD also increased measurably after four weeks. The iScience study was small, so it is better read as pharmacokinetic evidence than as proof of a health outcome.
That difference is the realistic expectation.
You can have a biological change without a dramatic sensation.
For someone using an NR product, the fair question is whether the precursor is present at a visible dose, whether the routine is tolerable, and whether you are giving it enough time to judge the outcome you actually care about.
Not every useful biological effect announces itself.
Who This Is For
This distinction matters most for people who are comparing NAD products and assume the word NAD identifies the active ingredient.
It also matters if you already take a multivitamin.
A multivitamin may contain niacin or nicotinamide as Vitamin B3, but that does not make it equivalent to a supplement built around NR. They share a metabolic family, not a trial design.
People chasing a fast energy boost should be especially cautious with the category.
NR is not caffeine.
A rise in NAD-related metabolites is not the same thing as stimulation, and a product that makes the two sound interchangeable is using the language too loosely.
If you are pregnant, breastfeeding, undergoing cancer treatment, or taking regular medication for a chronic condition, this is also a category where clinician input is sensible before adding concentrated precursors.
Dietary supplements are not approved by the FDA for effectiveness before sale. FDA consumer guidance is a reminder that the burden falls on the label, the evidence, and the buyer to keep ingredient identity and claims aligned.
How Long Before the Difference Matters
If the question is blood chemistry, changes can appear quickly.
The manufacturer-funded dose-ranging NR trial found measurable whole-blood NAD+ increases within two weeks.
If the question is how you feel, the answer is less predictable.
Human trials often run six to twelve weeks or longer because functional outcomes are harder to move and harder to measure than a blood metabolite.
That is also why switching products every few days teaches you almost nothing.
Pick the precursor.
Know the dose.
Then keep the routine stable long enough to judge the right endpoint.
Our guide to NAD+ dosage works through the milligram side of that decision, including why the biggest number on the shelf is not automatically the better one.
NAD Vitamin: Common Questions
Is NAD a vitamin?
No. NAD is a coenzyme used throughout cellular metabolism. Vitamin B3 is a nutrient family your body can use to make NAD, which is why the two are closely connected but not interchangeable.
Is nicotinamide riboside Vitamin B3?
NR is generally classified as a form or derivative within the Vitamin B3 family and serves as a precursor for NAD synthesis. That is different from saying NR and ordinary niacin supplements are identical.
Is niacin the same thing as NAD?
No. Niacin refers to Vitamin B3 forms such as nicotinic acid and nicotinamide. Your tissues can use B3 compounds to make NAD, but the nutrient and the coenzyme are different molecules with different jobs.
Is NR better than regular Vitamin B3 for raising NAD?
NR has direct human supplementation studies showing increases in NAD-related biomarkers at specific doses. That does not mean it is “better” for every nutritional purpose. If your goal is simply meeting the daily Vitamin B3 requirement, food and standard B3 sources already do that job.
Can I take an NAD supplement instead of Vitamin B3?
Do not treat them as substitutes for a documented nutrient deficiency. Vitamin B3 is an essential nutrient with established dietary requirements. NAD-focused supplements are usually used for a different reason, often to deliver a specific precursor above ordinary nutritional intake.
What is in Goli Renew NAD+ Gummies?
Goli Renew NAD+ Gummies use nicotinamide riboside chloride as the NAD precursor, with Vitamin B3 and Vitamin C alongside it. The suggested use provides 50 mg of NR chloride per two-gummy serving, taken twice daily for 100 mg across the full suggested day.
The name says NAD.
The ingredient strategy says precursor.
That is the distinction this entire category needs.
Choosing Goli Renew NAD+ by the Precursor, Not the Headline
Before the product, one objection is worth clearing up: NR is not a brand-new ingredient just because Goli Renew NAD+ is a newer product. NR has more than a decade of published human supplementation research. The clinical record belongs to the ingredient, not to the brand name on the bottle.
A viewer once asked me during a TikTok Live whether the Vitamin B3 in Renew made the NR redundant. It does not. The three ingredients have separate roles on the label.
Goli Renew NAD+ Gummies use nicotinamide riboside chloride as the named NAD precursor, with Vitamin B3 and Vitamin C alongside it. The current suggested use provides 50 mg of NR chloride per two-gummy serving, taken twice daily, for 100 mg across the full suggested day. The liquid-core format is designed to protect the NR from air, moisture, and heat until you chew it.
That is the part I care about.
I can identify the precursor, calculate the daily amount, and compare the same molecule against human trials rather than guessing what a proprietary “NAD complex” means.
That long-running scale matters here only because Goli has spent years turning daily supplement routines into a chewable format. That number cannot prove NR works, but it does explain why the company keeps putting complicated supplement routines into a format built around repeatability.
You May Also Like
Format can hide the same kind of category mistake in a completely different aisle. Beet gummies shows why the ingredient named on the front does not automatically transfer the research attached to beetroot juice.
The Bottom Line
Goli Renew NAD+ makes sense here because it does not ask the word NAD to do all the work. The formula identifies NR as the precursor and puts Vitamin B3 and Vitamin C beside it, which lets you separate the nutrient from the coenzyme and the precursor from the product name.
Today, turn over any NAD product you are considering and find the actual molecule. If it says NR, NMN, nicotinamide, or nicotinic acid, you are looking at a precursor pathway. If it says only NAD, do not assume the same human evidence applies.
Ten billion-plus gummy units are enough to make Goli a large brand, but they do not make a vague ingredient label more informative. In this category, one line on the Supplement Facts panel still matters more than the headline because the molecule determines which evidence you are actually buying.
References
- National Institutes of Health, Office of Dietary Supplements. “Niacin: Fact Sheet for Health Professionals.”
- Conze D, Brenner C, Kruger CL. “Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults.” Scientific Reports. 2019;9:9772. ChromaDex funded the study; two authors were employees and one author had intellectual-property and advisory ties to the company.
- Elhassan YS, Kluckova K, Fletcher RS, et al. “Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.” Cell Reports. 2019;28(7):1717-1728.e6.
- Dollerup OL, Christensen B, Svart M, et al. “Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity.” The Journal of Clinical Endocrinology & Metabolism. 2019;104(11):5703-5714.
- Gallagher C, Emmanuel OO. “NAD+ Supplementation for Anti-aging and Wellness: A PRISMA-guided Systematic Review of Preclinical and Clinical Evidence.” Ageing Research Reviews. 2026;103057.
- Alangari A, Arif J, Al Qureshah F, Alkhodairy F. “Narrative Review of Intravenous NAD+ and NAD+ Precursors in Wellness and Translational Medicine.” Frontiers in Aging. 2026.
- Berven H, Svensen M, Eikeland H, et al. “The NAD-brain Pharmacokinetic Study of NAD Augmentation in Blood and Brain Using Oral Precursor Supplementation.” iScience. 2026;29(3):114764.
- U.S. Food and Drug Administration. “Information for Consumers on Using Dietary Supplements.”
